Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Taylor Wessing launches the Taylor Wessing Patent Map
The Unified Patent Court guide
Countdown to the UPC, Part 7
Subscribe to Synapse

Life Sciences Issues in Corporate Transactions - Part 1

 

In the first of a two-part article, Colin McCall discusses the role of intellectual property rights in corporate transactions within the life sciences industry, explaining how they can help to ensure that the innovations at the centre of a life sciences business provide a return for those making an investment and others depending on the success of the business.

 

 

arrowView our previous articles

Topical Issues

 

BGW Federal Association of Health Industry trade mark contested

Chris Benson and Jocelyn Clarke report on a dispute concerning the acronym used in the BGW Federal Association of Health Industry trade mark...read more

 

Digital medicines

Tim Worden, Debbie Heywood and Paul England discuss the regulatory implications of the latest developments in 'digital medicine'...read more

 

The implementation of the Nagoya Protocol in the EU

Verena Bertram discusses the Nagaya Protocol and its implementation in the EU...read more

 

The implementation of the Nagoya Protocol in Germany

Verena Bertram discusses the Nagaya Protocol and its implementation in Germany...read more

 

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here